Professor David Kerr

Professor David Kerr Rhodes Professor of Clinical Pharmacology and Cancer Therapeutics Professor David Kerr is Rhodes Professor of Clinical Pharmacology and Cancer Therapeutics at the Department of Clinical Pharmacology, University of Oxford. He is working with colleagues in Oxford to build a new Institute for Cancer Medicine. He has an international reputation for treatment for and research into colorectal cancer, and he is developing new approaches to cancer treatment which involve gene therapy. The quality of his work has been recognised by the award of several international prizes and the first NHS Nye-Bevan award for innovation. He has published more than 350 articles in peer-reviewed journals and has contributed to many books on cancer. Professor Kerr has chaired the Advisory Board developing a vision for the future of Scotland’s Health Service and produced a 20 year plan for the future of the NHS in Scotland, Editor-in-Chief of Annals of Oncology, Europe’s premier medical oncology journal, and is on the editorial broad of several other journals including Nature Clinical Practice Oncology. He was elected Fellow of he Academy of Medical Sciences in 2000 and appointed Commander of the British Empire in 2002 and recently elected President of the European Society of Medical Oncology.

click here to return to SAB list